Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster Drugs

Published 6 days ago Positive
Ozempic Maker Novo Nordisk Lowers Growth Outlook of Its Blockbuster Drugs
Auto

Related Stocks

NOVO-B.CO Novo Nordisk A/...
Intensifying competition, pricing pressure and copycat versions of Ozempic and Wegovy hold back sales at the pharma giant.

Continue Reading

View comments

More News

Þuríður Björg Guðnadóttir Appointed CEO of Ljósleiðarinn

8 hours ago Positive

Saudi Arabia Plastic Recycling Market Analysis Report 2025-2034: Increasing Demand for Polyethylene Terephthalate (PET) to Aid Growth

8 hours ago Positive

Uxin joins hand with Yinchuan authorities for used car superstore

8 hours ago Positive

Saudi Arabia Pet Care Analysis, Forecast Trends and Outlook Report 2025-2034: Market to Grow at a CAGR of 7.2%, Fueled by Growing Birds Segment and Increasing Affordability of Pet Care Products

8 hours ago Positive

Intelligent Network Market Set to Reach USD 42.2 Billion by 2032, Growing at a CAGR of 27.49% | Research by SNS Insider

8 hours ago Positive